139 related articles for article (PubMed ID: 15376337)
1. Hepatocellular cancer, transplantation, and sirolimus.
Wall WJ
Liver Transpl; 2004 Oct; 10(10):1312-4. PubMed ID: 15376337
[No Abstract] [Full Text] [Related]
2. Impressive regression of primary liver cancer after treatment with sirolimus.
Rizell M; Cahlin C; Friman S; Hafström L; Lönn L; Olausson M; Lindner P
Acta Oncol; 2005; 44(5):496. PubMed ID: 16118084
[No Abstract] [Full Text] [Related]
3. Pilot study: rapamycin in advanced hepatocellular carcinoma.
Schöniger-Hekele M; Müller C
Aliment Pharmacol Ther; 2010 Sep; 32(6):763-8. PubMed ID: 20629977
[TBL] [Abstract][Full Text] [Related]
4. Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma.
Subbiah IM; Brown RE; Fallon MB
Hepatology; 2010 Oct; 52(4):1524. PubMed ID: 20680964
[No Abstract] [Full Text] [Related]
5. Angiosarcoma successfully treated with liver transplantation and sirolimus.
Xue M; Masand P; Thompson P; Finegold M; Leung DH
Pediatr Transplant; 2014 Jun; 18(4):E114-9. PubMed ID: 24641525
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.
Kornberg A; Küpper B; Tannapfel A; Thrum K; Wilberg J; Bärthel E; Settmacher U
Transpl Int; 2008 Jan; 21(1):96-9. PubMed ID: 17903182
[No Abstract] [Full Text] [Related]
7. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
Toso C; Meeberg GA; Bigam DL; Oberholzer J; Shapiro AM; Gutfreund K; Ma MM; Mason AL; Wong WW; Bain VG; Kneteman NM
Transplantation; 2007 May; 83(9):1162-8. PubMed ID: 17496530
[TBL] [Abstract][Full Text] [Related]
8. Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation.
Stippel DL; Kasper HU; Schleimer K; Töx U; Bangard C; Hölscher AH; Beckurts KT
Transplant Proc; 2005 Jun; 37(5):2185-7. PubMed ID: 15964374
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
[TBL] [Abstract][Full Text] [Related]
10. Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour.
Toh HC; Teo M; Ong KW; Lee V; Chan E; Lee AS; Vathsala A
Lancet Oncol; 2006 Nov; 7(11):955-7. PubMed ID: 17081922
[No Abstract] [Full Text] [Related]
11. Immunosuppressive drugs and the risk of cancer after organ transplantation.
Dantal J; Soulillou JP
N Engl J Med; 2005 Mar; 352(13):1371-3. PubMed ID: 15800234
[No Abstract] [Full Text] [Related]
12. [Recurrence of the initial disease after liver transplantation].
Dousset B; Calmus Y; Merrigi F; Houssin D
Gastroenterol Clin Biol; 1989 Dec; 13(12):984-96. PubMed ID: 2560439
[No Abstract] [Full Text] [Related]
13. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
[TBL] [Abstract][Full Text] [Related]
14. Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation.
Campbell MS; Rai J; Kozin E; Bloom RD; Markmann JF; Olthoff KM; Shaked A; Rajender Reddy K
Clin Transplant; 2007; 21(3):377-84. PubMed ID: 17488388
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma.
Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Mandell S; Kam I
Expert Opin Pharmacother; 2007 Jun; 8(9):1275-82. PubMed ID: 17563262
[TBL] [Abstract][Full Text] [Related]
16. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
18. Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
Pomfret EA
Transplantation; 2016 Jan; 100(1):14-5. PubMed ID: 26647108
[No Abstract] [Full Text] [Related]
19. Managing access to liver transplantation: implications for gastroenterology practice.
Brown R; Emond JC
Gastroenterology; 2007 Mar; 132(3):1152-63. PubMed ID: 17383434
[No Abstract] [Full Text] [Related]
20. Immunotherapy of hepatocellular carcinoma.
Greten TF; Manns MP; Korangy F
J Hepatol; 2006 Dec; 45(6):868-78. PubMed ID: 17046096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
